{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:51Z","timestamp":1787020371324,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science and technology project of the health planning committee of Sichuan","award":["21PJ050"],"award-info":[{"award-number":["21PJ050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis (AE), is often found associated with tumors such as thymoma, lung cancer, ovarian tumors, and breast cancer, and the tumors were generally detected during the screening process after the encephalitis initiated. The tumor is considered a trigger of AE, but the mechanism remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>A 53-year-old woman presented short-term memory loss two days after the primary cytoreduction for high-grade serous ovarian cancer (HGSOC, FIGO stage IC3). Cell-based assay found AMPAR CluA2 IgG positive in both serum (1:3.2) and cerebrospinal fluid (1:32). Moreover, mild AMPAR GluA1 and strong GluA2 expressions were also found positive in the paraffin sections of ovarian tumor tissue, indicating the ovarian cytoreduction surgery might stimulate the release of receptor antigens into the circulation system. The patient\u2019s condition deteriorated within two weeks, developing consciousness and autonomic dysfunction, leading to ICU admission. With oral steroids, intravenous immunoglobulin, plasmapheresis, and rituximab treatment, the patient\u2019s consciousness markedly improved after three months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We presented the first case of anti-AMPAR encephalitis developed right after the primary cytoreduction of a patient with HGSOC and retrieved paraneoplastic anti-AMPAR encephalitis cases (n\u2009=\u200966). Gynecologists should pay attention to patients who develop cognitive dysfunction or psychiatric symptoms shortly after the ovarian tumor resection and always include AE in the differentiation diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02636-1","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T07:01:59Z","timestamp":1695279719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review"],"prefix":"10.1186","volume":"23","author":[{"given":"Yue","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjiao","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"4","key":"2636_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424\u201334.","journal-title":"Ann Neurol"},{"key":"2636_CR2","doi-asserted-by":"publisher","first-page":"175628642093279","DOI":"10.1177\/1756286420932797","volume":"13","author":"A Vogrig","year":"2020","unstructured":"Vogrig A, Muniz-Castrillo S, Desestret V, Joubert B, Honnorat J. Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors. Ther Adv Neurol Disord. 2020;13:1756286420932797.","journal-title":"Ther Adv Neurol Disord"},{"key":"2636_CR3","doi-asserted-by":"publisher","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","volume":"12","author":"TY Zhang","year":"2021","unstructured":"Zhang TY, Cai MT, Zheng Y, et al. Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review. Front Immunol. 2021;12:652820.","journal-title":"Front Immunol"},{"key":"2636_CR4","first-page":"3263718","volume":"2016","author":"S Boangher","year":"2016","unstructured":"Boangher S, Mespouille P, Filip CM, Goffette S. Small-cell lung Cancer with positive Anti-NMDAR and Anti-AMPAR antibodies paraneoplastic limbic encephalitis. Case Rep Neurol Med. 2016;2016:3263718.","journal-title":"Case Rep Neurol Med"},{"issue":"12","key":"2636_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.7326\/L18-0593","volume":"170","author":"A Daneshmand","year":"2019","unstructured":"Daneshmand A, Goyal G, Markovic S, Zekeridou A, Wijdicks EFM, Hocker SE. Autoimmune encephalitis secondary to Melanoma. Ann Intern Med. 2019;170(12):905\u20136.","journal-title":"Ann Intern Med"},{"issue":"9","key":"2636_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","volume":"86","author":"M Dogan Onugoren","year":"2015","unstructured":"Dogan Onugoren M, Deuretzbacher D, Haensch CA, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry. 2015;86(9):965\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2636_CR7","doi-asserted-by":"publisher","first-page":"117306","DOI":"10.1016\/j.jns.2020.117306","volume":"421","author":"T Fukumoto","year":"2021","unstructured":"Fukumoto T, Miyamoto R, Fujita K, Murakami N, Matsui N, Izumi Y. Reversible mixed perfusion on (123)I-IMP SPECT in anti-AMPA receptor encephalitis: a case report. J Neurol Sci. 2021;421:117306.","journal-title":"J Neurol Sci"},{"issue":"5","key":"2636_CR8","doi-asserted-by":"publisher","first-page":"e1053","DOI":"10.1212\/NXI.0000000000001053","volume":"8","author":"M Guasp","year":"2021","unstructured":"Guasp M, Landa J, Martinez-Hernandez E, et al. Thymoma and Autoimmune Encephalitis: clinical manifestations and antibodies. Neurology(R) Neuroimmunol Neuroinflammation. 2021;8(5):e1053.","journal-title":"Neurology(R) Neuroimmunol Neuroinflammation"},{"issue":"24","key":"2636_CR9","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84(24):2403\u201312.","journal-title":"Neurology"},{"issue":"10","key":"2636_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","volume":"72","author":"B Joubert","year":"2015","unstructured":"Joubert B, Kerschen P, Zekeridou A, et al. Clinical spectrum of Encephalitis Associated with antibodies against the alpha-amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor: Case Series and Review of the literature. JAMA Neurol. 2015;72(10):1163\u20139.","journal-title":"JAMA Neurol"},{"issue":"7","key":"2636_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/MPH.0000000000001304","volume":"40","author":"DLT Koh","year":"2018","unstructured":"Koh DLT, Teoh E, Lau KK. An uncommon presentation of a primary bone Tumor: Anti-AMPA (Anti-\u03b1-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid) receptor Limbic\/Paraneoplastic encephalitis as a presenting feature of Ewing Sarcoma. J Pediatr Hematol Oncol. 2018;40(7):555\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"2636_CR12","first-page":"666","volume":"52","author":"ATT Kubota","year":"2012","unstructured":"Kubota ATT, Narukawa S, et al. Anti-Ma2, anti-NMDA-receptor and anti-GluR\u03b52 limbic encephalitis with testicular seminoma: short-term memory disturbance. Clin Neurol. 2012;52(9):666\u201371.","journal-title":"Clin Neurol"},{"issue":"2","key":"2636_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS. Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol. 2019;266(2):450\u201360.","journal-title":"J Neurol"},{"issue":"11","key":"2636_CR14","first-page":"e3581","volume":"10","author":"R Liu","year":"2018","unstructured":"Liu R, Dar AR, Tay KY, Nicolle MW, Inculet RI. Thymoma-associated Myasthenia Gravis in a Young Adult with Development of Paraneoplastic Limbic Encephalitis and systemic Lupus Erythematosus post-thymectomy: a Case Report. Cureus. 2018;10(11):e3581.","journal-title":"Cureus"},{"issue":"3","key":"2636_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","volume":"74","author":"LGR Bataller","year":"2010","unstructured":"Bataller LGR, Garc\u00eda-Escrig M, Mart\u00ednez B, Sevilla T, Blasco R, V\u00edlchez JJ, Dalmau J. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74(3):265\u20137.","journal-title":"Neurology"},{"issue":"1","key":"2636_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12883-021-02520-1","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fan S, Ren H, Zhou L, Guan H. Clinical characteristics and prognosis of anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis. BMC Neurol. 2021;21(1):490.","journal-title":"BMC Neurol"},{"issue":"11","key":"2636_CR17","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s10072-016-2680-0","volume":"37","author":"S Yang","year":"2016","unstructured":"Yang S, Qin J, Li J, et al. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2016;37(11):1853\u20135.","journal-title":"Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"issue":"2","key":"2636_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1941874419880423","volume":"10","author":"AL Safadi","year":"2020","unstructured":"Safadi AL, Wang T, Maria GD, et al. Recurrent Thymoma-Associated Paraneoplastic Encephalitis resulting from multiple antibodies: a Case Report. Neurohospitalist. 2020;10(2):139\u201342.","journal-title":"Neurohospitalist"},{"key":"2636_CR19","doi-asserted-by":"publisher","first-page":"827138","DOI":"10.3389\/fpsyt.2022.827138","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li J, Jiang F, et al. Autoimmune encephalitis with psychotic manifestations and cognitive impairment presenting as Schizophrenia: Case Report and Literature Review. Front Psychiatry. 2022;13:827138.","journal-title":"Front Psychiatry"},{"issue":"8","key":"2636_CR20","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s10072-021-05278-z","volume":"42","author":"S Qiao","year":"2021","unstructured":"Qiao S, Wu HK, Wang L, Zhang SC, Liu XW. Recurrent anti-AMPA receptor encephalitis associated with thymus cancer. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2021;42(8):3457\u201361.","journal-title":"Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"issue":"17","key":"2636_CR21","doi-asserted-by":"publisher","first-page":"e25694","DOI":"10.1097\/MD.0000000000025694","volume":"100","author":"J Yang","year":"2021","unstructured":"Yang J, Du J, Zhao J, et al. Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a case report. Medicine. 2021;100(17):e25694.","journal-title":"Medicine"},{"issue":"4","key":"2636_CR22","doi-asserted-by":"publisher","first-page":"e1019","DOI":"10.1212\/NXI.0000000000001019","volume":"8","author":"G Ricken","year":"2021","unstructured":"Ricken G, Zrzavy T, Macher S, et al. Autoimmune global amnesia as Manifestation of AMPAR encephalitis and neuropathologic findings. Neurology(R) Neuroimmunol Neuroinflammation. 2021;8(4):e1019.","journal-title":"Neurology(R) Neuroimmunol Neuroinflammation"},{"issue":"7","key":"2636_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757\u201368.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2636_CR24","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1212\/NXI.0000000000001052","volume":"8","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Thomas T, Eyre M, et al. International Consensus Recommendations for the treatment of Pediatric NMDAR antibody encephalitis. Neurology(R) Neuroimmunol Neuroinflammation. 2021;8(5):e1052.","journal-title":"Neurology(R) Neuroimmunol Neuroinflammation"},{"issue":"2","key":"2636_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2636_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/s-0034-1390394","volume":"34","author":"JJ Linnoila","year":"2014","unstructured":"Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol. 2014;34(4):458\u201366.","journal-title":"Semin Neurol"},{"issue":"11","key":"2636_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","volume":"78","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Eyre M, Molteni E, et al. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate receptor antibody encephalitis: a Meta-analysis. JAMA Neurol. 2021;78(11):1333\u201344.","journal-title":"JAMA Neurol"},{"issue":"2","key":"2636_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000448942","volume":"62","author":"A Musella","year":"2017","unstructured":"Musella A, Vertechy L, Romito A, et al. Bevacizumab in Ovarian Cancer: state of the art and unanswered questions. Chemotherapy. 2017;62(2):111\u201320.","journal-title":"Chemotherapy"},{"issue":"9","key":"2636_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/COC.0000000000001024","volume":"46","author":"A Giannini","year":"2023","unstructured":"Giannini A, Di Dio C, Di Donato V, et al. PARP inhibitors in newly diagnosed and recurrent ovarian Cancer. Am J Clin Oncol. 2023;46(9):414\u20139.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"2636_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jviscsurg.2020.12.012","volume":"158","author":"JGO Arquilli\u00e8re","year":"2021","unstructured":"Arquilli\u00e8re JGO, Passot G. Cytoreductive surgery in peritoneal carcinomatosis. J Visc Surg. 2021;158(3):258\u201364.","journal-title":"J Visc Surg"},{"issue":"2","key":"2636_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev. 2017;97(2):839\u201387.","journal-title":"Physiol Rev"},{"issue":"22","key":"2636_CR32","doi-asserted-by":"publisher","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","volume":"94","author":"E Martinez-Hernandez","year":"2020","unstructured":"Martinez-Hernandez E, Guasp M, Garcia-Serra A, et al. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology. 2020;94(22):e2302\u201310.","journal-title":"Neurology"},{"issue":"3","key":"2636_CR33","doi-asserted-by":"publisher","first-page":"e01540","DOI":"10.1002\/brb3.1540","volume":"10","author":"YC Wei","year":"2020","unstructured":"Wei YC, Tseng JR, Wu CL, et al. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: case report and literature review. Brain Behav. 2020;10(3):e01540.","journal-title":"Brain Behav"},{"key":"2636_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2017.11.010","volume":"79","author":"N Chourasia","year":"2018","unstructured":"Chourasia N, Watkins MW, Lankford JE, Kass JS, Kamdar A. An infant born to a mother with Anti-N-Methyl-d-Aspartate receptor encephalitis. Pediatr Neurol. 2018;79:65\u20138.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"2636_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s12013-014-0302-0","volume":"71","author":"S Li","year":"2015","unstructured":"Li S, Zhao A. A case of anti-NMDAR encephalitis induced by ovarian teratoma. Cell Biochem Biophys. 2015;71(2):1011\u20134.","journal-title":"Cell Biochem Biophys"},{"issue":"49","key":"2636_CR36","doi-asserted-by":"publisher","first-page":"e9177","DOI":"10.1097\/MD.0000000000009177","volume":"96","author":"Z Liang","year":"2017","unstructured":"Liang Z, Yang S, Sun X, et al. Teratoma-associated anti-NMDAR encephalitis: two cases report and literature review. Med (Baltim). 2017;96(49):e9177.","journal-title":"Med (Baltim)"},{"issue":"1","key":"2636_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13256-017-1388-y","volume":"11","author":"MC Maggio","year":"2017","unstructured":"Maggio MC, Mastrangelo G, Skabar A, et al. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports. J Med Case Rep. 2017;11(1):225.","journal-title":"J Med Case Rep"},{"issue":"5","key":"2636_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.braindev.2016.12.003","volume":"39","author":"T Omata","year":"2017","unstructured":"Omata T, Kodama K, Watanabe Y, et al. Ovarian teratoma development after anti-NMDA receptor encephalitis treatment. Brain Dev. 2017;39(5):448\u201351.","journal-title":"Brain Dev"},{"issue":"5","key":"2636_CR39","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00737-017-0751-8","volume":"20","author":"J Voice","year":"2017","unstructured":"Voice J, Ponterio JM, Lakhi N. Psychosis secondary to an incidental teratoma: a heads-up for psychiatrists and gynecologists. Arch Womens Ment Health. 2017;20(5):703\u20137.","journal-title":"Arch Womens Ment Health"},{"issue":"7","key":"2636_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2169\/internalmedicine.9682-17","volume":"57","author":"T Omi","year":"2018","unstructured":"Omi T, Kinoshita M, Nishikawa A, et al. Clinical relapse of Anti-AMPAR Encephalitis Associated with recurrence of Thymoma. Intern Med. 2018;57(7):1011\u20133.","journal-title":"Intern Med"},{"issue":"1","key":"2636_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0002-9378(84)90294-1","volume":"149","author":"RA Sack","year":"1984","unstructured":"Sack RA, Kroener WF. Hypokalemia of various etiologies complicating elective surgical procedures. Am J Obstet Gynecol. 1984;149(1):74\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2636_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jpainsymman.2007.11.004","volume":"36","author":"MO Delgado-Guay","year":"2008","unstructured":"Delgado-Guay MO, Yennurajalingam S, Bruera E. Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: an interdisciplinary approach to treatment. J Pain Symptom Manage. 2008;36(4):442\u20139.","journal-title":"J Pain Symptom Manage"},{"issue":"suppl1","key":"2636_CR43","doi-asserted-by":"publisher","first-page":"i115","DOI":"10.1093\/bja\/aex354","volume":"119","author":"MJ Needham","year":"2017","unstructured":"Needham MJ, Webb CE, Bryden DC. Postoperative cognitive dysfunction and dementia: what we need to know and do. Br J Anaesth. 2017;119(suppl1):i115\u201325.","journal-title":"Br J Anaesth"},{"issue":"1","key":"2636_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aev403","volume":"116","author":"P Braude","year":"2016","unstructured":"Braude P, Partridge JS, Hardwick J, Shipway DJ, Dhesi JK. Geriatricians in perioperative medicine: developing subspecialty training. Br J Anaesth. 2016;116(1):4\u20136.","journal-title":"Br J Anaesth"},{"key":"2636_CR45","doi-asserted-by":"crossref","unstructured":"Borella F, Bertero L, Morrone A et al. Brain metastases from ovarian Cancer: current evidence in diagnosis, treatment, and prognosis. Cancers (Basel) 2020;12(8).","DOI":"10.3390\/cancers12082156"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:04:27Z","timestamp":1700388267000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2636"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02636-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was granted by the Ethics Committee of West China Second University Hospital, Sichuan University (2022117).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient in accordance with the 1975 Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"507"}}